Correvio Pharma Corp (CORV) Stock Price, Forecast & Analysis
USA - NASDAQ:CORV -
CORV Key Statistics, Chart & Performance
The current stock price of CORV is 0.4199 null. In the past month the price increased by 1.57%. In the past year, price decreased by -81.25%.
CORV Latest News, Press Relases and Analysis
About CORV
Company Profile
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
Company Info
Correvio Pharma Corp
1441 Creekside Drive 6th Floor
Vancouver A1 V6J 4S7
CEO: Mark Corrigan
Phone: 604-677-6905
Correvio Pharma Corp / CORV FAQ
Can you describe the business of Correvio Pharma Corp?
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
What is the stock price of Correvio Pharma Corp today?
The current stock price of CORV is 0.4199 null. The price increased by 0.82% in the last trading session.
Does Correvio Pharma Corp pay dividends?
CORV does not pay a dividend.
What is the ChartMill rating of Correvio Pharma Corp stock?
CORV has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
CORV Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CORV. When comparing the yearly performance of all stocks, CORV is a bad performer in the overall market: 95.72% of all stocks are doing better.
CORV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CORV. CORV may be in some trouble as it scores bad on both profitability and health.
CORV Financial Highlights
Over the last trailing twelve months CORV reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS increased by 11.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -107.81% | ||
| ROA | -59.26% | ||
| ROE | N/A | ||
| Debt/Equity | 21.5 |